Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47,768 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia.
Gu R, Liu F, Zou D, Xu Y, Lu Y, Liu B, Liu W, Chen X, Liu K, Guo Y, Gong X, Lv R, Chen X, Zhou C, Zhong M, Wang H, Wei H, Mi Y, Qiu L, Lv L, Wang M, Wang Y, Zhu X, Wang J. Gu R, et al. Among authors: lu y. J Hematol Oncol. 2020 Sep 7;13(1):122. doi: 10.1186/s13045-020-00953-8. J Hematol Oncol. 2020. PMID: 32894185 Free PMC article. Clinical Trial.
A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer.
Lin F, Xiong M, Hao W, Song Y, Liu R, Yang Y, Yuan X, Fan D, Zhang Y, Hao M, Ye Z, Lu Y, Zhang Y, Wang J, Xiong D. Lin F, et al. Among authors: lu y. Front Oncol. 2021 Jan 5;10:615534. doi: 10.3389/fonc.2020.615534. eCollection 2020. Front Oncol. 2021. PMID: 33469516 Free PMC article.
Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity.
Wang Z, Lu Y, Liu Y, Mou J, Liu X, Chen M, Wang Y, Xu Y, Rao Q, Xing H, Tang K, Tian Z, Wang B, Qi W, Wang M, Qiu S, Xiong D, Wang J. Wang Z, et al. Among authors: lu y. Cancer Commun (Lond). 2023 Oct;43(10):1178-1182. doi: 10.1002/cac2.12474. Epub 2023 Jul 31. Cancer Commun (Lond). 2023. PMID: 37525513 Free PMC article. No abstract available.
Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection.
Guo Y, Zhang G, Yang Q, Xie X, Lu Y, Cheng X, Wang H, Liang J, Tang J, Gao Y, Shang H, Dai J, Shi Y, Zhou J, Zhou J, Guo H, Yang H, Qi J, Liu L, Ma S, Zhang B, Huo Q, Xie Y, Wu J, Dong F, Zhang S, Lou Z, Gao Y, Song Z, Wang W, Sun Z, Yang X, Xiong D, Liu F, Chen X, Zhu P, Wang X, Cheng T, Rao Z. Guo Y, et al. Among authors: lu y. Nat Commun. 2023 Jun 15;14(1):3537. doi: 10.1038/s41467-023-39267-x. Nat Commun. 2023. PMID: 37322000 Free PMC article.
47,768 results
You have reached the last available page of results. Please see the User Guide for more information.